Market Reports Center One Stop Market Research Shop Cancer Diagnostics Device Market Share, Size, Price, Growth, Trends and Forecast 2016 – 2020 Technavio Announces the Publication of its Research Report – Global Cancer Diagnostic Devices Market 2016-2020 Technavio recognizes the following companies as the key players in the global cancer diagnostics devices market: Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen, and Roche Diagnostics. Other Prominent Vendors in the market are: Affymetrix, Ambry Genetics, Annoroad, Aviva Biosciences, Biochain, Bio-Rad, Cancer Genetics, Cepheid, CompanionDx, DiagnoCure, Epic Sciences, Epigenomics, Genomic Health, HalioDX, Hologic, Illumina, Myriad Genetics, Thermo Fisher Scientific, Ventana Medical Systems, and Vysis. Download Brochure now @ https://marketreportscenter.com/reports/313744/global-cancerdiagnostics-device-market-2016-2020 Commenting on the report, an analyst from Technavio’ s team said: “A trend which will definitely boost market growth is product approvals and launches. The significant focus on cancer diagnosis has led to the development of novel cancer diagnostic devices in the market. Many of these products have received approval from regulatory agencies such as the FDA and Health Canada. The availability of these advanced tests and associated diagnostic devices has allowed medical facilities to adopt them for cancer diagnosis. For instance, Beckman Coulter's VERIS molecular diagnostic system and VERIS human cytomegalovirus assay received CE mark approval in May 2014.” According to the report, a key growth driver is the demand for personalized medicines. Proteins and genes control and manage the biochemical functions of the body. Any defect in the structure of a particular protein or gene can lead to specific conditions and disorders. The production of personalized drugs depends on the identification and study of protein and gene expressions. These drugs are customized based on an individual's protein or genetic profiles. Personalized medicines have high demand in oncology therapy since conventional cancer drug therapies fail to achieve desired patient outcomes. Further, the report states that one challenge that could impact market growth is the high cost of developing companion diagnostics. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. About the Cancer Diagnostic Devices Market An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options. The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor. Technavio’ s analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Abbott Diagnostics • Agilent Technologies • BD • bioMérieux • Qiagen • Roche Diagnostics Other prominent vendors • Affymetrix • Ambry Genetics • Annoroad • Aviva Biosciences • Biochain • Bio-Rad • Cancer Genetics • Cepheid • CompanionDx • DiagnoCure • Epic Sciences • Epigenomics • Genomic Health • HalioDX • Hologic • Illumina • Myriad Genetics • Thermo Fisher Scientific • Ventana Medical Systems • Vysis Request for discount @ https://marketreportscenter.com/request-discount/313744 Market driver • Demand for personalized medicines • For a full, detailed list, view our report Market challenge • High cost of developing companion diagnostics • For a full, detailed list, view our report Market trend • Demand for personalized medicines • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’ s time when you purchase this market report. Details are provided within the report. To Get Request Sample for this Reports: https://marketreportscenter.com/request-sample/313744 For more information content with us; Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com
Technavio recognizes the following companies as the key players in the global cancer diagnostics devices market: Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen, and Roche Diagnostics.
© Copyright 2024 Paperzz
